Source: Annual Congress 2005 - Systemic effects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. C. MontesdeOca, S. H. Torres, J. B. De Sanctis, A. Mata, N. Hernández, C. Tálamo (Caracas, Venezuela). Inflammatory markers in skeletal muscle of low and normal weight COPD patients. Eur Respir J 2005; 26: Suppl. 49, 4198

Member's Comments

No comment yet.

Related content which might interest you: Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Source: Eur Respir J 2003; 22: 2S-4S Year: 2003 Can leptin and IL-6 influence the nutritional status in COPD patients? Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Body composition by bioelectrical impedance predicts mortality in COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients? Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 The regional distribution of body fat mass (BFM) in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Sex differences in mortality in patients with COPD Source: Eur Respir J 2009; 33: 528-535 Year: 2009 Body mass index, disease control and airway inflammation in asthmatic patients Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 The role of regional distribution (RD) of body fat mass (BFM) in fat-bone interactions in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Correlation between body mass index and spirometry parameters in chronic obstructive pulmonary disease patients with ischemic heart disease and obesity. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Fat-free mass depletion and functional exercise capacity in COPD patients Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 The association between fat mass, disease control and airway inflammation in refractory asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Low fat-free mass and body mass index are associated with worse survival in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010